General Information of Drug (ID: DMSVD2R)

Drug Name
SGN-CD228A Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMSVD2R

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanotransferrin (MELTF) TT8OBT3 TRFM_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04042480) A Study of SGN-CD228A in Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Seagen.